FGK Clinical Research GmbH participated in ‘BIO KOREA 5’ held at COEX, Seoul for three days from May 10 (Wed) to 12 (Fri).
FGK Clinical Research is a European-based clinical trial agency (CRO) optimized for cooperation with small and medium-sized medical device, biotechnology, and pharmaceutical companies. Since its founding in 2002, more than 210 employees have been employed, most of them based in Munich, Germany, and a branch office in Berlin.
Dedicated to all phases and fields of clinical development, he has accumulated experience in major medical fields such as specific oncology, cardiology, neurology, dermatology, and gastroenterology. In addition to this, officials explained that they are proud of their expertise in alternative medicine. In addition to drug development services, it is also responsible for guiding various innovative medical devices within the increasingly demanding clinical research system.
It provides various clinical trial and consulting services in Europe and the United States, covering pharmaceutical licensing work, project management and supervision, medical technology safety assurance, data management, biostatistics, electronic solutions for clinical trials, and quality assurance.
FGK Clinical Research operates FGK Pharmacovigilance (side effect monitoring) and FGK Representative Service (contact service) as subsidiaries. Through this, QPPV service, side effect monitoring service such as PSMF management, and legal representation service for non-European customers who want to conduct clinical research or obtain marketing permission in the EU and EEA are also supported.
An official from FGK said, “We want to introduce the advantages of our clinical trial program to potential customers at this exhibition and raise awareness in the Korean market.”
Meanwhile, ‘BIO KOREA 18’, which celebrated its 2023th this year, was hosted by the Korea Health Industry Development Institute and Chungcheongbuk-do. Since 2006, BIO KOREA, which has been striving to promote the global status and continuous growth of the Korean health industry, has been strengthening its position as Korea’s representative bio-health international convention with world-renowned scholars and business experts participating every year. BIO KOREA 2023, together with domestic and foreign companies related to the health industry such as bio, pharmaceuticals, medical devices, cosmetics, and food, as well as companies and institutions of interest such as consulting, academia, and related organizations, offers various programs such as conferences, business partnering, exhibitions, and invest fairs. it went on
→ Go to the BIO KOREA 2023 news special page
